相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis: a systematic review based on evidence
Clara Cortell Fuster et al.
JOURNAL OF DERMATOLOGICAL TREATMENT (2022)
Perfect match: mTOR inhibitors and tuberous sclerosis complex
Cong Luo et al.
ORPHANET JOURNAL OF RARE DISEASES (2022)
Genotype-phenotype correlation of renal lesions in the tuberous sclerosis complex
Yoshinari Muto et al.
HUMAN GENOME VARIATION (2022)
The PRISMA 2020 statement: an updated guideline for reporting systematic reviews
Matthew J. Page et al.
BMJ-BRITISH MEDICAL JOURNAL (2021)
The efficacy and safety of topical rapamycin-calcitriol for facial angiofibromas in patients with tuberous sclerosis complex: a prospective, double-blind, randomized clinical trial
P. L. Chen et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
A novel TSC2 c.4511 T > C missense variant associated with tuberous sclerosis complex
Shunzhi He et al.
BMC MEDICAL GENETICS (2020)
Improved health-related quality of life in patients treated with topical sirolimus for facial angiofibroma associated with tuberous sclerosis complex
Takashi Hatano et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Systematic Review and Network Meta-Analysis of Immune Checkpoint Inhibitors in Combination with Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Carcinoma
Hsiao-Ling Chen et al.
CANCERS (2020)
Efficacy and safety of mTOR inhibitors (rapamycin and its analogues) for tuberous sclerosis complex: a meta-analysis
Min Li et al.
ORPHANET JOURNAL OF RARE DISEASES (2019)
The revision of the SI-the result of three decades of progress in metrology
Michael Stock et al.
METROLOGIA (2019)
Tuberous sclerosis complex: review based on new diagnostic criteria
Larissa Karine Leite Portocarrero et al.
ANAIS BRASILEIROS DE DERMATOLOGIA (2018)
Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex A Randomized Clinical Trial
Mari Wataya-Kaneda et al.
JAMA DERMATOLOGY (2018)
Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex The TREATMENT Randomized Clinical Trial
Mary Kay Koenig et al.
JAMA DERMATOLOGY (2018)
The use of rapamycin in patients with tuberous sclerosis complex: Long-term results
Mehmet Canpolat et al.
EPILEPSY & BEHAVIOR (2018)
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Multivariate and network meta-analysis of multiple outcomes and multiple treatments: rationale, concepts, and examples
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2017)
Efficacy and Safety of Topical Sirolimus Therapy for Facial Angiofibromas in the Tuberous Sclerosis Complex A Randomized Clinical Trial
Mari Wataya-Kaneda et al.
JAMA DERMATOLOGY (2017)
Genetics of tuberous sclerosis complex: implications for clinical practice
Carolina Caban et al.
APPLICATION OF CLINICAL GENETICS (2017)
The Role of mTOR Inhibitors in the Treatment of Patients with Tuberous Sclerosis Complex: Evidence-based and Expert Opinions
Paolo Curatolo et al.
DRUGS (2016)
mTORC1 and mTORC2 regulate skin morphogenesis and epidermal barrier formation
Xiaolei Ding et al.
NATURE COMMUNICATIONS (2016)
The PRISMA Extension Statement for Reporting of Systematic Reviews Incorporating Network Meta-analyses of Health Care Interventions: Checklist and Explanations
Brian Hutton et al.
ANNALS OF INTERNAL MEDICINE (2015)
Advances in the therapeutic use of mammalian target of rapamycin (mTOR) inhibitors in dermatology
Alexander L. Fogel et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2015)
Mosaic and Intronic Mutations in TSC1/TSC2 Explain the Majority of TSC Patients with No Mutation Identified by Conventional Testing
Magdalena E. Tyburczy et al.
PLOS GENETICS (2015)
Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in Tuberous Sclerosis Complex
R. Balestri et al.
JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY (2015)
Network meta-analysis
Ian R. White
STATA JOURNAL (2015)
Regulation of innate immune cell function by mTOR
Thomas Weichhart et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Facial Angiofibroma Severity Index (FASI): reliability assessment of a new tool developed to measure severity and responsiveness to therapy in tuberous sclerosis-associated facial angiofibroma
R. Salido-Vallejo et al.
CLINICAL AND EXPERIMENTAL DERMATOLOGY (2014)
First left-right comparative study of topical rapamycin vs. vehicle for facial angiofibromas in patients with tuberous sclerosis complex
M. Tanaka et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Topical Rapamycin Therapy to Alleviate the Cutaneous Manifestations of Tuberous Sclerosis Complex
Mary Kay Koenig et al.
Drugs in research & development (2013)
Dramatic Improvement of Facial Angiofibromas in Tuberous Sclerosis With Topical Rapamycin: Optimizing a Treatment Protocol
Cynthia M. C. DeKlotz
ARCHIVES OF DERMATOLOGY (2011)
Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
Georgia Salanti et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis
Francis X. McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
New Technique Using Combined Pulsed Dye Laser and Fractional Resurfacing for Treating Facial Angiofibromas in Tuberous Sclerosis
Elliot T. Weiss et al.
LASERS IN SURGERY AND MEDICINE (2010)
More Than Numbers: The Power of Graphs in Meta-Analysis
Leon Bax et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Tuberous sclerosis complex:: Advances in diagnosis, genetics, and management
Robert A. Schwartz et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2007)
Current and future immunosuppressive strategies in renal transplantation
KL Hardinger et al.
PHARMACOTHERAPY (2004)
General principles for the definition of the base units in the SI
V Kose et al.
METROLOGIA (2003)
Treatment of angiofibromas with a scanning carbon dioxide laser: A clinicopathologic study with long-term follow-up
RCA Bittencourt et al.
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY (2001)
The tuberous sclerosis-1 (TSC1) gene product hamartin suppresses cell growth and augments the expression of the TSC2 product tuberin by inhibiting its ubiquitination
G Benvenuto et al.
ONCOGENE (2000)
分享论文
